Gazi University Faculty of Health Sciences Department of Physical Therapy and Rehabilitation
Ankara, Turkey (Türkiye)
NCT Number: NCT03007602
Hematologic malignancy is a tumor of myeloid or lymphatic cells that affects lymph nodes with the involvement of blood, bone marrow or other organs.There are various treatment options for hematological malignancies ranging from follow-up to single or multiple agent chemotherapy, radiotherapy, immunotherapy and autologous or allogeneic hematopoietic stem cell transplantations (HSCT). The general recommendation for patients is to relax and avoid intense exercise, regardless of the devastating consequences of neglecting physical exercise. Patients also go to relaxation by reducing their activity to avoid fatigue, which leads to loss of muscle strength and endurance. As a consequence of all, fatigue, vomiting, weight loss, anemia, depression, decreased aerobic capacity, muscle weakness, decreased physical function and poor quality of life are observed in HSCT recipients. It has been shown that physical exercises improve oxygen consumption, depression and fatigue, cardiorespiratory fitness, muscle strength and physical well-being in patients with hematologic malignancies who are at stages of various treatments. In literature, effects of upper extremity aerobic exercise training have been investigated in patients with spinal cord injury, neuromuscular diseases, claudication, hypertension, multiple sclerosis, heart failure, paraplegic patients and healthy individuals. Results of these studies has shown that upper extremity aerobic exercise training improves walking distance, increases oxygen pulse, muscle strength and endurance of upper extremity. No study was observed to investigate the effects of upper extremity aerobic exercise training on exercise capacity and quality of life in HSCT recipients, as we know. For this reason, our aim is to investigate the effects of upper extremity aerobic exercise training on exercise capacity and quality of life in HSCT recipients.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Ankara, Turkey (Türkiye)
Minimum 30 allogeneic and autologous HSCT recipients (˃100 days past post-transplant status) will be included. Before and after 6-week upper extremity aerobic exercise training, maximal and submaximal exercise capacity, respiratory and peripheral muscle strength, pulmonary functions, physical activity, dyspnea and fatigue perception, anxiety, depression and quality of life were evaluated. Primary outcome measurements were exercise capacity and quality of life , secondary outcomes were respiratory and peripheral muscle strength, pulmonary functions, physical activity, dyspnea and fatigue perception, anxiety and depression.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Range of maximal heart rate is being followed by a polar band during supervised session each week.
Aerobic exercise is being trained for 30 min-per/day, 3 days/week, 6 weeks. All sessions are being performed by a physiotherapist at cardiopulmonary rehabilitation department.
Time frame: 6-week
Evaluated with 6-minute walking test
Time frame: 6-week
Evaluated with spirometer
Time frame: 6-week
Evaluated with a hand-held dynamometer for peripheral muscles, mouth pressure device for respiratory muscle strength
Time frame: 6-week
Evaluated with peak flow meter
Time frame: 6-week
Evaluated with a metabolic holter
Time frame: 6-week
Evaluated using Fatigue Severity Scale
Time frame: 6-week
Evaluated using Hospital Anxiety and Depression Scale
Time frame: 6-week
Evaluated using Modified Medical Research Council Dyspnea scale (MMRC) and Modified Borg Scale
Time frame: 6-week
evaluated using QOL using European Organization for Research and Treatment of Cancer QOL Questionnaire (EORTCQOL)
Time frame: 6-week
evaluated using Modified Incremental Shuttle Walk Test
Gazi University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03654599
Anxiety, Anxiety Disorders
Phoenix, Arizona, United States
View Trial DetailsNCT02677987
Behavior, Behavioral Symptoms
Chicago, Illinois, United States
View Trial DetailsNCT01873794
Breast Cancer, Breast Diseases
Hackensack, New Jersey, United States
View Trial DetailsNCT06904053
Hematopoietic Stem Cell Transplantation
Bethesda, Maryland, United States
View Trial Details